Cargando…
Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine
Vaccine solutions rarely reach the public until after an outbreak abates; an Ebola vaccine was approved 5 years after peak outbreak and SARS, MERS, and Zika vaccines are still in clinical development. Despite massive leaps forward in rapid science, other regulatory bottlenecks are hamstringing the g...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293492/ https://www.ncbi.nlm.nih.gov/pubmed/32600777 http://dx.doi.org/10.1016/j.tibtech.2020.06.004 |